Northwestern Mutual Wealth Management’s Co-Diagnostics CODX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-3
Closed -$125 3657
2024
Q3
$125 Buy
+3
New +$115 ﹤0.01% 3477
2023
Q2
Hold
0
-$1 3381
2023
Q1
Hold
0
3336
2022
Q1
Sell
-33
Closed -$9K 3144
2021
Q4
$9K Buy
+33
New +$8.66K ﹤0.01% 2590

Other funds holding CODX

Northwestern Mutual Wealth Management's CODX Position: Q4 2024 in Review

Northwestern Mutual Wealth Management sold out of Co-Diagnostics (CODX) in Q4 2024, closing a stake of 3 shares — an estimated $125 sold.

Northwestern Mutual Wealth Management first reported a position in CODX in Q4 2021 and held it in 2 quarters. The position peaked at $9K in Q4 2021. 37 funds tracked by Wall St. Rank hold CODX as of Q4 2024.

  • Northwestern Mutual Wealth Management reported no remaining Co-Diagnostics position as of Q4 2024 after selling out during the quarter.
  • Northwestern Mutual Wealth Management sold 3 Co-Diagnostics shares in Q4 2024, an estimated $125.
  • Northwestern Mutual Wealth Management first reported a position in Co-Diagnostics in Q4 2021 and held it in 2 quarters.
  • Northwestern Mutual Wealth Management's Co-Diagnostics position peaked at $9K in Q4 2021.
  • 37 funds tracked by Wall St. Rank held Co-Diagnostics as of Q4 2024.

Based on Northwestern Mutual Wealth Management's 13F filing for Q4 2024, filed 11 Feb 2025.